TY - JOUR AU - Pfaeffli Dale, Leila AU - Whittaker, Robyn AU - Jiang, Yannan AU - Stewart, Ralph AU - Rolleston, Anna AU - Maddison, Ralph PY - 2015 DA - 2015/10/21 TI -冠心病自我管理的短信和互联网支持:来自Text4Heart随机对照试验JO - J Med Internet Res SP - e237 VL - 17 IS - 10kw -短信KW -移动健康KW -手机KW -心血管疾病KW -干预KW -生活方式改变KW -行为AB -背景:移动技术有潜力以适当的成本提供行为改变干预(mHealth)以减少冠心病(CHD)。之前的研究主要集中在单一行为上;然而，心脏康复(CR)作为冠心病自我管理的一个组成部分，需要解决多种危险因素。目的:目的是调查在常规护理(传统CR)之外，一个由医疗保健提供的综合CR计划(Text4Heart)的有效性，以提高对推荐生活方式行为(戒烟、体育活动、健康饮食和无害饮酒)的依从性。方法:在被诊断为冠心病的新西兰成年人中进行了一项2组、平行、随机对照试验。参与者在医院内被招募，并被鼓励参加以中心为基础的CR(常规护理控制)。此外，干预组接受了24周的个性化移动健康计划，该计划以社会认知理论为框架，由全自动的每日短消息服务(SMS)文本消息和支持网站发送。主要结局是在3个月和6个月时使用自我报告的综合健康行为评分(≥3)来衡量对健康生活方式行为的坚持程度。次要结局包括6个月时的临床结局、药物依从性评分、自我效能、疾病感知、焦虑和/或抑郁。 Baseline and 6-month follow-up assessments (unblinded) were conducted in person. Results: Eligible patients (N=123) recruited from 2 large metropolitan hospitals were randomized to the intervention (n=61) or the control (n=62) group. Participants were predominantly male (100/123, 81.3%), New Zealand European (73/123, 59.3%), with a mean age of 59.5 (SD 11.1) years. A significant treatment effect in favor of the intervention was observed for the primary outcome at 3 months (AOR 2.55, 95% CI 1.12-5.84; P=.03), but not at 6 months (AOR 1.93, 95% CI 0.83-4.53; P=.13). The intervention group reported significantly greater medication adherence score (mean difference: 0.58, 95% CI 0.19-0.97; P=.004). The majority of intervention participants reported reading all their text messages (52/61, 85%). The number of visits to the website per person ranged from zero to 100 (median 3) over the 6-month intervention period. Conclusions: A mHealth CR intervention plus usual care showed a positive effect on adherence to multiple lifestyle behavior changes at 3 months in New Zealand adults with CHD compared to usual care alone. The effect was not sustained to the end of the 6-month intervention. A larger study is needed to determine the size of the effect in the longer term and whether the change in behavior reduces adverse cardiovascular events. Trial Registration: ACTRN 12613000901707; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364758&isReview=true (Archived by WebCite at http://www.webcitation.org/6c4qhcHKt) SN - 1438-8871 UR - //www.mybigtv.com/2015/10/e237/ UR - https://doi.org/10.2196/jmir.4944 UR - http://www.ncbi.nlm.nih.gov/pubmed/26490012 DO - 10.2196/jmir.4944 ID - info:doi/10.2196/jmir.4944 ER -